ARCHIVES

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

NCI to Close Clinical Branch at Frederick, Move Patients, Protocols To Bethesda

May 17, 1996

ACO Leaders Meet With Key White House, Hill Aides

March 29, 1985

NCI Outlines Need For $3,873 Billion To Seize Cancer Research Opportunities

October 30, 1998

In Brief: Esparza, Young, Busch, Rush Head Oncology Societies; Hipple Centers Honors Harry Eagle

June 2, 1989

In Brief: Bishop No Longer Candidate For NCI Director; HHS Endorses Intramural Scientist Klausner

April 21, 1995

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013